People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Newomics Inc. | — | Biotechnology | Seed | $3.9M | $148.7M | 2020 |
| Pain Therapeutics Inc | — | Pharmaceuticals | Seed | $1.1M | $42.1M | 2018 |
Patrick Scannon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Scannon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael O'Donnell | 1 | 11 |
| Saira Ramasastry | 1 | 4 |
| Ted Hou | 1 | 2 |
| Nadav Friedmann | 1 | 1 |
| Sanford Robertson | 1 | 1 |
| Robert Gussin | 1 | 1 |
| Remi Barbier | 1 | 1 |
| Pan Mao | 1 | 1 |
| Daojing Wang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.